INCA participa de estudo inédito sobre novo fármaco para câncer do colo do útero

Thumbnail Image

Files

Informe-INCA-2022-417-4-INCA-participa-de.pdf (219.13 KB)

Date

2022-03

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

INCA

Abstract

Description

Keywords

Neoplasias do Colo do Útero/terapia, Uterine Cervical Neoplasms/therapy, Neoplasias del Cuello Uterino/terapia, Avaliação de Medicamentos, Drug Evaluation, Evaluación de Medicamentos, Cemiplimabe, Melo, Andréia Cristina de

Citation

URI

http://sr-vmlxaph03:8080/jspui/handle/123456789/6276

Collections

Informe INCA 417

Endorsement

Review

Supplemented By

Referenced By